Inventor · disambiguated record
Roberto Iacone
Also filed as: IACONE ROBERTO
9 granted patents·12 pending applications·15 citations·filing 2013–2023
80Inventor score
Top patents by PatentIndex Score
21 records- 0184US10428108B2Difluoroketamide derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Oct 1, 2019·5 cites·24 claims
- 0284US9980929B2Trifluoromethylpropanamide derivativesHOFFMANN LA ROCHE·Filed 2017·Granted May 29, 2018·5 cites·26 claims
- 0382US10724000B2Small molecule based conversion of somatic cells into neural crest cellsHOFFMANN LA ROCHE·Filed 2016·Granted Jul 28, 2020·4 cites·10 claims
- 0474US11633488B2Modified IL-2 polypeptides and uses thereofBRIGHT PEAK THERAPEUTICS AG·Filed 2021·Granted Apr 25, 2023·1 cites·20 claims
- 0564US2025179170A1Use of anti-claudin-1 antibodies to increase t cell availabilityALENTIS THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0663US2020157546A1Antisense oligonucleotides for modulating htra1 expressionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0762US2022042022A1Antisense oligonucleotides for modulating htra1 expressionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0860US2025326835A1Use of anti-claudin-1 antibodies to treat cholangiocarcinomaALENTIS THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0956US2020399641A1Antisense oligonucleotides for modulating htra1 expressionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1053US2020182861A1Method for differentiation of pluripotent stem cells into vascular bed cellsHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1149US9297025B2Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)HOFFMANN LA ROCHE·Filed 2013·Granted Mar 29, 2016·0 cites·12 claims
- 1249US2015017674A1Method for differentiation of pluripotent stem cells into vascular bed cellsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1348US2019055564A1Antisense oligonucleotides for modulating htra1 expressionHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1448US2023138047A1Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseasesUNIV STRASBOURG·Filed 2020·Application pending·0 cites
- 1547US10519450B2Antisense oligonucleotides for modulating HTRA1 expressionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 31, 2019·0 cites·42 claims
- 1645US2022056091A1Modified il-18 polypeptides and uses thereofBRIGHT PEAK THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1744US11059858B2Difluoroketamide derivatives as HtrA1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Jul 13, 2021·0 cites·38 claims
- 1844US11014963B2Trifluoromethylpropanamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted May 25, 2021·0 cites·48 claims
- 1941US2020378970A1Companion diagnostic for htra1 rna antagonistsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2038US10138468B2Method for differentiation of pluripotent stem cells into multi-competent renal precursorsHOFFMANN LA ROCHE·Filed 2016·Granted Nov 27, 2018·0 cites·11 claims
- 2138US2016369234A1Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roberto Iacone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →